North America Vacuum Blood Collection Tube Market to Grow at a CAGR of 7.3% to reach US$ 2,041.98 million from 2022 to 2030

The North American vacuum blood collection tube market value is projected to grow from US$ 1,164.83 million in 2022 to US$ 2,041.98 million by 2030. The vacuum blood collection tube market is further anticipated to record a CAGR of 7.3% from 2022 to 2030. 

Market Insights and Analyst View:

Vacuum tubes are utilized to draw a specific volume of blood. Blood specimens are collected in tubes with various additives such as EDTA, heparin, and serum for various types of tests. These additives are identified by the color of the cap. Key factors driving the vacuum blood collection tube market growth include the increasing number of surgeries and growing blood donation rate and blood tests. However, the risk associated with needlestick injuries hinders the market growth.

Growth Drivers and Restraints:

North America has witnessed an overall increase in the demand for surgical procedures in recent years. This can be attributed to factors such as advancements in medical technology, an aging population, and a greater emphasis on proactive healthcare management. With the rise in the prevalence of heart, liver, kidney, and other chronic diseases, the number of surgeries performed annually has also increased notably. According to the report “Chronic Kidney Disease in the United States, 2023” by the Centers for Disease Control and Prevention, 14% of ~35.5 million people in the US suffer from chronic kidney disease (CKD). CKD has a higher prevalence in people aged 65 years or older (34%) than in people aged 45–64 years (12%) or 18–44 years (6%). Furthermore, the “Life and expectations post-kidney transplant: a qualitative analysis of patient responses” study published in 2019 reported that ~17,600 kidney transplants are performed each year in the US.

According to the American Joint Replacement Registry (AJRR) on Knee and Hip Arthroplasty’s 7th annual report, ~2 million hip and knee procedures were performed between 2019 and 2020 in the US. Angioplasty and atherectomy are two of the most common procedures performed in the US. According to the most recent interventional cardiology procedural data, more than 965,000 angioplasties are performed in the US each year. An angioplasty, also known as percutaneous coronary intervention (PCI), is a procedure in which a stent is inserted into a blocked or constricted artery. The development of advanced surgical techniques and procedures has increased the range and complexity of surgeries performed. Minimally invasive procedures, robotic-assisted surgeries, and other innovative techniques have gained popularity due to their potential for faster recovery, reduced complications, and improved patient outcomes. These advancements require accurate and reliable diagnostic information, which, in turn, drives the demand for vacuum blood collection tubes to collect samples for pre-operative testing and post-operative monitoring.

Advances in anesthesia and blood management also play a crucial role in surgical procedures, and accurate pre-operative patient assessment and monitoring are essential for successful outcomes. Blood management, including appropriate interventions to prevent excessive bleeding or clotting, also contributes to surgical success and patient safety. Vacuum blood collection tubes are used for pre-operative blood tests to assess coagulation parameters, blood typing, and screening for infectious diseases, helping healthcare providers make informed decisions regarding anesthesia management and blood transfusions during surgeries.

An increase in organ transplant procedures performed across the US results in an upsurge of blood transfer procedures that need collection units such as bags and tubes. The American Cancer Society estimates that more than 1.9 million people are likely to be diagnosed with cancer in 2023. Many cancer patients need to undergo blood transfusion procedures as a part of the management of chemotherapy or radiation side effects or to make up for the blood lost during surgeries. According to the United Network for Organ Sharing, 42,887 organ transplants were performed in the US in 2022, recording an increase of 3.7% over 2021. The American Red Cross Blood Services reported that every two seconds, a need for blood arises for cancer therapies, surgeries, traumatic injuries, and other chronic illness treatments in the US. Thus, the rise in the number of surgeries and blood transfusions fuels the demand for vacuum blood collection tubes, boosting the North American vacuum blood collection tube market

However, there is a risk of percutaneous injury associated with a needle. According to the American Medical Association estimates, each year, ~600,000 to 800,000 needlestick injuries occur in the US. There are various risks associated with blood drawing, such as pain, bruising, infection, bleeding, fainting, and hematoma at the injection site. Several diseases are transmitted through these injuries, including hepatitis B, acquired immune deficiency syndrome (AIDS), and hepatitis C. As a result of accidental punctures, hazardous fluids can be injected into the body through the skin by contaminated needles. Injecting hazardous drugs is possible; however, the most significant concern is infection with infectious fluids, especially in the blood. Even small amounts of infectious fluid can spread diseases. Thus, these factors have also surfaced as a significant deterrent for the North American vacuum blood collection tube market.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

North America Vacuum Blood Collection Tube Market: Strategic Insights

Market Size Value in	US$ 1,164.83 million in 2022
Market Size Value by	US$ 2,041.98 million by 2030
Growth rate	CAGR of 7.3% from 2022 to 2030
Forecast Period	2022-2030
Base Year	2022

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

 Speak to Analyst

Report Segmentation and Scope:

The North American vacuum blood collection tube market is segmented on the basis of product, material, application, and end user. Based on product, the market is divided into heparin tubes, EDTA tubes, glucose tubes, serum separating tubes, ERS tubes, and others. The vacuum blood collection tube market, by material, is segmented into PET, polypropylene, and tempered glass. Based on application, the market is segmented into blood routine examination, biochemical test, and coagulation testing. In terms of end users, the vacuum blood collection tube market is segmented into hospitals and clinics, ambulatory surgical centers, pathology labs, and blood banks. The North American vacuum blood collection tube market, by country, is segmented into the US, Canada, and Mexico.

Segmental Analysis:

The North America vacuum blood collection tube market, by product, is segmented into heparin tubes, EDTA tubes, glucose tubes, serum separating tubes, ERS tubes, and others. In 2022, the serum separating tubes segment held the largest share of the market. The EDTA tubes segment is expected to grow at the highest CAGR during 2022–2030. Serum separating tubes (SSTs) are coated with micro silica particles, which induces clotting blood, and the barrier gel effectively separates serum from fibrin and cells while restricting substance exchange between blood cell and serum. During centrifugation, the clot activator (silica particle) speeds up clotting and acts as a barrier gel, separating serum from fibrin and cells. SSTs are commonly used for blood serum biochemistry, immunology, serology, drug testing, etc. Both non-vacuum and vacuum gel and clot activator tubes are available in the market.

Vacuum Blood Collection Tube Market, by Product– 2022 and 2030

Access Data

Based on material, the North America vacuum blood collection tube market is segmented into PET, polypropylene, and tempered glass. The PET segment held the largest share of the market in 2022 and is expected to register the highest CAGR during 2022–2030.

Based on application, the North America vacuum blood collection tube market is segmented into blood routine examination, biochemical test, and coagulation testing. The blood routine examination segment held the largest share of the market in 2022, and the biochemical test segment is anticipated to register the highest CAGR in the market during 2022–2030.

Based on end users, the North America vacuum blood collection tube market is segmented into hospitals and clinics, ambulatory surgical centers, pathology labs, and blood banks. The hospitals and clinics segment held the largest share of the market in 2022, and the blood banks segment is anticipated to register the highest CAGR in the market during 2022–2030.

Regional Analysis:

The US is estimated to hold the largest share of the vacuum blood collection tube market during 2022–2030. Although the US has a well-developed healthcare sector equipped with highly advanced equipment and instruments, it experiences increasing incidences of chronic diseases and multiple organ dysfunction syndromes or sepsis, which is likely to favor the growth of the vacuum blood collection tube market. According to the report “Chronic Kidney Disease in the United States, 2023” by the Centers for Disease Control and Prevention, 14% of ~35.5 million people suffer from chronic kidney disease (CKD) in the US. Furthermore, 9 in 10 people are not aware that they are suffering from CKD. Hypertension, diabetes, heart disease, and obesity are the causes of CKD. Thus, with the growing incidences of high blood pressure, heart disease, diabetes, and obesity, the demand for blood testing for diagnostics and research purposes increases in the US, which propels the vacuum blood collection tube market growth in North America. 

An increase in organ transplant procedures performed across the US can be associated with an upsurge in blood transfer procedures that require blood testing to identify blood groups and tissue types. The American Cancer Society estimates that more than 1.9 million people will be diagnosed with cancer in 2023. Many cancer patients need to undergo blood transfusion procedures as a part of the management of chemotherapy or radiation side effects or to make up for the blood lost during surgeries. According to the United Network for Organ Sharing (UNOS), 42,887 organ transplants were performed in the US in 2022, recording an increase of 3.7% over 2021. The American Red Cross Blood Services reported that someone in the US requires blood for cancer therapies, surgeries, traumatic injuries, and other chronic illness treatments every two seconds. Thus, the demand for vacuum blood collection tubes increases with the increasing demand for blood testing due to rising incidences of kidney and other chronic diseases in the US.

Industry Developments and Future Opportunities:

Various initiatives by key players operating in the global vacuum blood collection tube market are listed below:

1. In July 2023, SARSTEDT AG & Co KG launched 360 solutions that will be used to improve specimen quality, reduce turnaround time, and automate labs of all sizes with customizable modular systems. The company has demonstrated S-Monovette and Tempus600 at the AACC Annual Scientific Meeting & Clinical Lab Expo. The conferences have helped in showcasing products' specifications.
2. In June 2022, Cardinal Health announced the acquisition of ScalaMed, a HIPAA-compliant smart platform that transmits medicines directly to patients via a secure mobile app. ScalaMed's technology and assets are being transferred to Outcomes, a Cardinal Health firm, as part of the transaction. ScalaMed shifts prescription management from the provider to the patient, allowing patients to transfer prescriptions issued by their clinician to any pharmacy for the initial fill. The platform provides patients with increased freedom, easier access, and price comparison when choosing a pharmacy.
3. In April 2021, Greiner Bio-One launched VACUETTE line, the innovative evoprotect safety Blood Collection Set. It meets the requirements of the EU Directive 2010/32. It is an innovative safety mechanism that can be conveniently activated while the needle is in the vein protects blood collection staff against potential injuries.

Competitive Landscape and Key Companies:

Becton Dickinson and Co, Greiner Bio-One International GmbH, Sekisui Chemical Co Ltd, SARSTEDT AG & Co KG, Cardinal Health Inc, McKesson Corp, HemaSource Inc, and Medline Industries LP are among the prominent players operating in the vacuum blood collection tube market. These companies focus on new technologies, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios.